GSA Capital Partners LLP decreased its position in Danaher Co. (NYSE:DHR) by 65.5% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 6,071 shares of the conglomerate’s stock after selling 11,529 shares during the quarter. GSA Capital Partners LLP’s holdings in Danaher were worth $599,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Mount Yale Investment Advisors LLC bought a new stake in Danaher during the 1st quarter worth about $103,000. IMS Capital Management bought a new stake in Danaher during the 2nd quarter worth about $107,000. BerganKDV Wealth Management LLC bought a new stake in Danaher during the 2nd quarter worth about $111,000. Kaizen Advisory LLC grew its holdings in Danaher by 150.3% during the 2nd quarter. Kaizen Advisory LLC now owns 1,464 shares of the conglomerate’s stock worth $144,000 after acquiring an additional 879 shares during the last quarter. Finally, Carroll Financial Associates Inc. grew its holdings in Danaher by 62.5% during the 2nd quarter. Carroll Financial Associates Inc. now owns 1,485 shares of the conglomerate’s stock worth $146,000 after acquiring an additional 571 shares during the last quarter. 76.90% of the stock is currently owned by institutional investors and hedge funds.
Shares of NYSE:DHR traded down $1.37 during mid-day trading on Monday, reaching $105.61. The stock had a trading volume of 2,162,200 shares, compared to its average volume of 2,362,199. The company has a market capitalization of $76.04 billion, a price-to-earnings ratio of 26.21, a P/E/G ratio of 2.08 and a beta of 1.01. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.50 and a quick ratio of 1.07. Danaher Co. has a twelve month low of $83.81 and a twelve month high of $110.13.
Danaher (NYSE:DHR) last announced its quarterly earnings results on Thursday, July 19th. The conglomerate reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.09 by $0.06. The business had revenue of $4.98 billion for the quarter, compared to the consensus estimate of $4.91 billion. Danaher had a net margin of 13.84% and a return on equity of 11.55%. Danaher’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period last year, the company posted $0.99 EPS. Equities research analysts expect that Danaher Co. will post 4.49 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 26th. Shareholders of record on Friday, September 28th will be issued a dividend of $0.16 per share. The ex-dividend date is Thursday, September 27th. This represents a $0.64 annualized dividend and a yield of 0.61%. Danaher’s dividend payout ratio (DPR) is currently 15.88%.
A number of equities research analysts have commented on the stock. Zacks Investment Research lowered shares of Danaher from a “hold” rating to a “sell” rating in a report on Monday, July 16th. ValuEngine lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Thursday, June 21st. Royal Bank of Canada increased their price objective on shares of Danaher to $107.00 and gave the stock a “positive” rating in a report on Thursday, July 19th. They noted that the move was a valuation call. Morgan Stanley increased their price objective on shares of Danaher from $120.00 to $122.00 and gave the stock an “overweight” rating in a report on Friday, July 20th. Finally, Bank of America set a $113.00 price objective on shares of Danaher and gave the stock a “buy” rating in a report on Thursday, July 19th. Sixteen analysts have rated the stock with a buy rating, Danaher has an average rating of “Buy” and an average target price of $111.28.
In other Danaher news, SVP Robert S. Lutz sold 14,555 shares of the firm’s stock in a transaction that occurred on Tuesday, July 24th. The shares were sold at an average price of $103.93, for a total transaction of $1,512,701.15. Following the sale, the senior vice president now directly owns 18,044 shares in the company, valued at approximately $1,875,312.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP William K. Daniel sold 103,086 shares of the firm’s stock in a transaction that occurred on Friday, August 10th. The stock was sold at an average price of $100.63, for a total transaction of $10,373,544.18. Following the sale, the executive vice president now owns 167,080 shares in the company, valued at $16,813,260.40. The disclosure for this sale can be found here. Insiders have sold a total of 299,961 shares of company stock worth $30,619,691 over the last 90 days. Corporate insiders own 11.90% of the company’s stock.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
See Also: How a Put Option Works
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.